Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemical Industries Development (CID) is a leading Egyptian pharmaceutical manufacturer and a subsidiary of the state-owned Holding Company for Pharmaceuticals, Chemicals and Medical Appliances (HoldiPharma). Established in 1947, CID produces a diverse portfolio of human and veterinary medicines, including antibiotics, analgesics, and vitamins. The company operates extensive manufacturing facilities in Giza, adhering to Good Manufacturing Practice (GMP) standards to supply both the domestic Egyptian market and international markets across Africa and the Middle East. CID is recognized for its long-standing history in the region and its role in providing affordable essential medicines. Its product range encompasses various dosage forms such as tablets, capsules, syrups, and ointments. The company also engages in contract manufacturing for other pharmaceutical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CID Egypt.